Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer

P Yu, Y Wang, D Yuan, Y Sun, S Qin, T Li - Frontiers in Immunology, 2023 - frontiersin.org
Ovarian cancer remains a challenging disease with limited treatment options and poor
prognosis. The tumor microenvironment (TME) plays a crucial role in tumor growth …

New clinical trial design in precision medicine: discovery, development and direction

XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

Endothelial cells in tumor microenvironment: insights and perspectives

P Leone, E Malerba, N Susca, E Favoino… - Frontiers in …, 2024 - frontiersin.org
The tumor microenvironment is a highly complex and dynamic mixture of cell types,
including tumor, immune and endothelial cells (ECs), soluble factors (cytokines …

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications

J Fang, Y Lu, J Zheng, X Jiang, H Shen, X Shang… - Cell Death & …, 2023 - nature.com
The tumor microenvironment (TME) is a highly intricate milieu, comprising a multitude of
components, including immune cells and stromal cells, that exert a profound influence on …

Iron, Ferroptosis, and Head and Neck Cancer

Y Teng, L Gao, AA Mäkitie, E Florek… - International Journal of …, 2023 - mdpi.com
Ferroptosis is an iron-dependent regulatory form of cell death characterized by the
accumulation of intracellular reactive oxygen species and lipid peroxidation. It plays a critical …

Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial

H Gong, S Tian, H Ding, L Tao, L Wang, J Wang… - Nature …, 2024 - nature.com
This phase II trial aimed to determine the efficacy and safety of induction
chemoimmunotherapy of camrelizumab plus modified TPF in locally advanced …

Deciphering the Tumor–Immune–Microbe Interactions in HPV-Negative Head and Neck Cancer

M Hu, S Coleman, MZH Fadlullah, D Spakowicz… - Genes, 2023 - mdpi.com
Patients with human papillomavirus-negative head and neck squamous cell carcinoma
(HPV-negative HNSCC) have worse outcomes than HPV-positive HNSCC. In our study, we …

Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: The paradigm of radiotherapy

S Logotheti, A Pavlopoulou, HK Rudsari… - Pharmacology & …, 2024 - Elsevier
Advances in cancer therapeutics have improved patient survival rates. However, cancer
survivors may suffer from adverse events either at the time of therapy or later in life …

Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer

F Yang, C Yuan, F Chen, ZS Qin, NC Schmitt… - Journal of Experimental …, 2024 - Springer
Background While T cell-activating immunotherapies against recurrent head and neck
squamous cell carcinoma (HNSCC) have shown impressive results in clinical trials, they are …

From standard therapies to monoclonal antibodies and immune checkpoint inhibitors–an update for reconstructive surgeons on common oncological cases

L Knoedler, L Huelsboemer, K Hollmann… - Frontiers in …, 2024 - frontiersin.org
Malignancies represent a persisting worldwide health burden. Tumor treatment is commonly
based on surgical and/or non-surgical therapies. In the recent decade, novel non-surgical …